MSB 7.69% $1.19 mesoblast limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-42

  1. 209 Posts.
    lightbulb Created with Sketch. 24
    @whytee Reaching way too hard by being unnecessarily pedantic about something that had clear meaning and trying to turn it into a sleight: obviously, given the context of where things were at with the FDA and what could be communicated to the market, he meant that labeling was the final item of an agenda of things to discuss before FDA could make a decision and provide feedback to the company.

    you are so incredibly bad faith it's astounding, and it's why you get ragged on for being a short seller.
    Last edited by AnotherOneWon: 30/04/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.